The University of Chicago Header Logo

Samuel Hellman

Concepts (303)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
26
2015
2961
1.410
Why?
Neoplasms
21
2023
2966
1.290
Why?
Neoplasm Metastasis
19
2016
1090
1.110
Why?
Radiotherapy
6
2014
331
0.700
Why?
Prostatic Neoplasms
9
2007
1750
0.700
Why?
Epigenesis, Genetic
1
2023
493
0.680
Why?
Antineoplastic Agents
8
2015
2382
0.500
Why?
Knowledge
1
2014
29
0.490
Why?
Education, Medical
2
2014
238
0.470
Why?
Neovascularization, Pathologic
6
2004
364
0.470
Why?
Models, Theoretical
3
2005
485
0.450
Why?
Physicians, Primary Care
1
2014
105
0.440
Why?
Randomized Controlled Trials as Topic
5
2004
836
0.420
Why?
Humans
72
2023
87465
0.410
Why?
Lymphatic Metastasis
8
2003
497
0.410
Why?
Physician-Patient Relations
4
2007
615
0.400
Why?
Radiation, Ionizing
4
2010
121
0.380
Why?
Radiation Oncology
3
1997
120
0.360
Why?
Human Experimentation
1
2010
39
0.350
Why?
Nucleoside-Diphosphate Kinase
2
2000
12
0.350
Why?
Ethics, Research
1
2010
52
0.340
Why?
Monomeric GTP-Binding Proteins
2
2000
19
0.340
Why?
Disease-Free Survival
12
2011
1208
0.340
Why?
Patient Advocacy
3
2015
50
0.330
Why?
MicroRNAs
4
2015
542
0.320
Why?
Chemotherapy, Adjuvant
8
2005
473
0.310
Why?
Physician's Role
4
2005
176
0.310
Why?
Genetic Therapy
9
2008
353
0.300
Why?
Models, Economic
1
2007
60
0.300
Why?
Hematopoiesis
1
2008
164
0.290
Why?
Neoplasm Recurrence, Local
5
2005
1343
0.290
Why?
Neoplastic Stem Cells
1
2008
157
0.280
Why?
Decision Making
3
2007
650
0.270
Why?
Tumor Necrosis Factor-alpha
7
2008
692
0.270
Why?
Liver Neoplasms
3
2018
759
0.270
Why?
Prostatectomy
3
2007
475
0.270
Why?
Prognosis
11
2005
3706
0.270
Why?
Hematopoietic Stem Cells
1
2008
297
0.270
Why?
Androgen Antagonists
2
2005
150
0.270
Why?
Attitude of Health Personnel
2
2005
637
0.260
Why?
Transcription Factors
6
2004
1619
0.260
Why?
Antineoplastic Agents, Hormonal
2
2003
155
0.250
Why?
Ethics, Medical
3
2000
308
0.250
Why?
Prostate-Specific Antigen
2
1998
356
0.250
Why?
Colorectal Neoplasms
3
2018
955
0.250
Why?
Attitude to Health
1
2005
221
0.240
Why?
Nitriles
1
2004
154
0.230
Why?
Triazoles
1
2004
98
0.230
Why?
Biomedical Research
3
2014
385
0.230
Why?
Epithelial-Mesenchymal Transition
1
2023
94
0.220
Why?
History, 20th Century
3
2010
313
0.220
Why?
Sentinel Lymph Node Biopsy
1
2003
69
0.220
Why?
Managed Care Programs
2
2000
42
0.210
Why?
Brachytherapy
1
2003
120
0.210
Why?
Disease Progression
8
2012
1473
0.200
Why?
Melanoma
2
2013
461
0.200
Why?
Proliferating Cell Nuclear Antigen
2
2000
67
0.200
Why?
Lymph Node Excision
1
2003
220
0.190
Why?
Lymph Nodes
4
2000
545
0.190
Why?
Aged
16
2018
18609
0.190
Why?
Biomarkers, Tumor
3
2003
1505
0.190
Why?
Medical Oncology
2
2014
372
0.180
Why?
Female
31
2018
45140
0.180
Why?
Carcinoma
1
2003
440
0.180
Why?
Survival Analysis
6
2013
1535
0.180
Why?
Combined Modality Therapy
9
2005
1695
0.180
Why?
Clinical Trials as Topic
4
2014
1138
0.170
Why?
Skin Neoplasms
1
2004
556
0.170
Why?
Cadherins
1
2000
159
0.170
Why?
Middle Aged
16
2018
25302
0.170
Why?
Radiosurgery
2
2013
274
0.170
Why?
Mammography
2
2000
465
0.160
Why?
Radiotherapy, Adjuvant
4
2005
294
0.160
Why?
Gene Amplification
1
2018
132
0.150
Why?
History, 21st Century
2
2009
176
0.140
Why?
Immediate-Early Proteins
4
2004
166
0.140
Why?
Mastectomy
2
2004
243
0.140
Why?
Quality of Health Care
1
2000
382
0.140
Why?
Antigens, Neoplasm
1
1998
330
0.140
Why?
Prescription Fees
1
2015
10
0.130
Why?
Disease Models, Animal
4
2016
2299
0.130
Why?
Consumer Advocacy
1
1995
10
0.130
Why?
Insurance Coverage
1
1996
117
0.130
Why?
Health Care Rationing
1
1996
83
0.130
Why?
Microcirculation
3
2000
106
0.130
Why?
Aged, 80 and over
7
2018
6606
0.130
Why?
United States
7
2015
6763
0.130
Why?
Chromosomes, Human, Pair 14
1
2015
49
0.130
Why?
Drug Costs
1
2015
63
0.120
Why?
Erectile Dysfunction
2
2007
74
0.120
Why?
Neoplasm Staging
5
2004
1960
0.120
Why?
Patients
1
1995
101
0.120
Why?
Medical Laboratory Science
1
1994
7
0.120
Why?
Radiotherapy, Computer-Assisted
2
2008
25
0.120
Why?
Clinical Medicine
1
1994
34
0.120
Why?
Aging
1
1998
696
0.120
Why?
Life Expectancy
1
1994
86
0.110
Why?
Genetic Engineering
1
1994
115
0.110
Why?
Patient Participation
1
2015
216
0.110
Why?
Urinary Incontinence
2
2007
209
0.110
Why?
Male
13
2018
41449
0.110
Why?
Adult
12
2018
25988
0.110
Why?
Health Care Reform
1
1994
86
0.110
Why?
History, 19th Century
2
2009
60
0.110
Why?
Data Interpretation, Statistical
2
2004
299
0.100
Why?
Treatment Outcome
6
2013
8051
0.100
Why?
Diagnostic Imaging
1
2015
474
0.100
Why?
Evidence-Based Medicine
2
2005
425
0.100
Why?
Neoplasm Transplantation
6
2016
396
0.090
Why?
Animals
15
2016
26935
0.090
Why?
Age Factors
3
2007
1847
0.090
Why?
Informed Consent
2
2010
272
0.090
Why?
Philosophy, Medical
2
2005
17
0.090
Why?
Follow-Up Studies
4
2000
3638
0.090
Why?
Multivariate Analysis
3
1998
994
0.090
Why?
Ohio
1
2010
38
0.090
Why?
Tamoxifen
2
2004
168
0.090
Why?
Hodgkin Disease
1
1991
179
0.090
Why?
NM23 Nucleoside Diphosphate Kinases
2
2000
6
0.090
Why?
Biological Evolution
1
1997
934
0.090
Why?
Lung
2
2012
1225
0.080
Why?
Research Subjects
1
2010
73
0.080
Why?
X-Ray Therapy
1
2008
6
0.080
Why?
Universities
1
2010
145
0.080
Why?
Analysis of Variance
2
2004
901
0.080
Why?
Cell Line, Tumor
5
2015
2494
0.080
Why?
Lung Neoplasms
3
2013
2308
0.080
Why?
Military Personnel
1
2010
87
0.080
Why?
Survival Rate
3
2012
1869
0.080
Why?
Radiation-Sensitizing Agents
1
2008
96
0.080
Why?
Adenocarcinoma
3
2012
1179
0.080
Why?
Melanoma, Experimental
1
2008
103
0.080
Why?
Radiotherapy, Conformal
1
2008
84
0.080
Why?
Philosophy
1
2007
9
0.080
Why?
Urethral Stricture
1
2007
14
0.080
Why?
Rectal Diseases
1
2007
24
0.080
Why?
Practice Patterns, Physicians'
1
1993
592
0.080
Why?
Critical Pathways
1
2007
36
0.080
Why?
DNA-Binding Proteins
4
2004
1224
0.070
Why?
Mutation
1
2018
4060
0.070
Why?
Actuarial Analysis
2
1997
66
0.070
Why?
Time Factors
4
2005
5258
0.070
Why?
Phenotype
3
2015
2414
0.070
Why?
Fund Raising
1
2005
2
0.070
Why?
Academies and Institutes
1
2006
31
0.070
Why?
Predictive Value of Tests
3
2003
1686
0.070
Why?
Dermatology
1
2006
36
0.070
Why?
Gene Expression Regulation
3
2002
1956
0.070
Why?
Immunohistochemistry
3
2000
1779
0.070
Why?
Gene Expression Profiling
3
2018
1410
0.060
Why?
Trastuzumab
1
2005
68
0.060
Why?
Heterografts
2
2015
102
0.060
Why?
Sample Size
1
2005
129
0.060
Why?
Mastectomy, Radical
2
1995
10
0.060
Why?
Drug Administration Schedule
2
2003
900
0.060
Why?
Patient Satisfaction
1
2007
456
0.060
Why?
Antibiotics, Antineoplastic
1
2004
114
0.060
Why?
Radiation Dosage
2
2011
226
0.060
Why?
Databases, Factual
1
2007
837
0.060
Why?
Doxorubicin
1
2004
297
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2004
2493
0.050
Why?
Carcinoma, Lewis Lung
2
2000
24
0.050
Why?
Cell Transformation, Neoplastic
1
2005
444
0.050
Why?
Neoplasm Invasiveness
1
2004
571
0.050
Why?
Mice
9
2015
11577
0.050
Why?
Interdisciplinary Communication
1
2003
130
0.050
Why?
Surgical Procedures, Operative
1
2004
189
0.050
Why?
Early Growth Response Protein 1
4
2004
54
0.050
Why?
Kaplan-Meier Estimate
2
2018
855
0.050
Why?
Lymphedema
1
2003
77
0.050
Why?
Transcriptional Activation
1
2002
286
0.050
Why?
Sensitivity and Specificity
2
2003
2016
0.050
Why?
Risk
1
2003
660
0.050
Why?
Coumarins
1
2000
13
0.050
Why?
Dose-Response Relationship, Radiation
2
2000
188
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2003
696
0.050
Why?
Risk Assessment
2
2005
2252
0.050
Why?
Immunity, Cellular
1
2001
178
0.050
Why?
Tumor Cells, Cultured
5
2002
1048
0.050
Why?
Gene Expression
2
2015
1296
0.050
Why?
Cisplatin
1
2002
614
0.040
Why?
Databases as Topic
1
2000
93
0.040
Why?
Mice, Nude
5
2002
809
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2005
942
0.040
Why?
Cancer Vaccines
1
2001
159
0.040
Why?
Carcinoma, Lobular
1
2000
81
0.040
Why?
Antibodies, Monoclonal
1
2005
1393
0.040
Why?
Plasminogen
1
1998
41
0.040
Why?
Apoptosis
3
2008
1703
0.040
Why?
Genetic Vectors
4
2004
442
0.040
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
9
0.040
Why?
Carcinoma, Ductal, Breast
1
2000
157
0.040
Why?
Research
2
2003
251
0.040
Why?
Transcription, Genetic
1
2002
1143
0.040
Why?
Receptor, Notch1
1
2018
94
0.040
Why?
Paraffin Embedding
1
1997
78
0.040
Why?
Severity of Illness Index
1
2003
1815
0.040
Why?
Xenograft Model Antitumor Assays
2
2011
464
0.040
Why?
Mutagenesis
1
1997
200
0.040
Why?
Axilla
1
1997
102
0.040
Why?
Adrenalectomy
1
1996
45
0.040
Why?
Neoplasm Proteins
1
2000
539
0.040
Why?
Insurance, Health
1
1998
157
0.040
Why?
Ovariectomy
1
1996
81
0.040
Why?
Peptide Fragments
1
1998
459
0.040
Why?
HCT116 Cells
1
2016
154
0.040
Why?
Researcher-Subject Relations
1
1996
4
0.030
Why?
Vascular Endothelial Growth Factor A
1
2018
416
0.030
Why?
Molecular Biology
1
1996
89
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2004
1096
0.030
Why?
Social Responsibility
1
1996
58
0.030
Why?
Immunotherapy
1
2001
646
0.030
Why?
Fibrosarcoma
1
1995
85
0.030
Why?
Luminescent Measurements
1
2015
62
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
1996
178
0.030
Why?
DNA Repair
1
1997
359
0.030
Why?
Cell Nucleus
1
1997
588
0.030
Why?
Laryngeal Neoplasms
1
1995
89
0.030
Why?
Algorithms
1
2003
1848
0.030
Why?
Mice, Inbred NOD
1
2015
190
0.030
Why?
Likelihood Functions
1
1995
252
0.030
Why?
Mice, SCID
1
2015
261
0.030
Why?
Proportional Hazards Models
1
1996
849
0.030
Why?
Research Design
2
2003
592
0.030
Why?
Neoplasms, Experimental
1
1995
269
0.030
Why?
Tumor Burden
1
2015
301
0.030
Why?
Social Values
1
1994
44
0.030
Why?
Socioeconomic Factors
1
1996
569
0.030
Why?
Regression Analysis
1
1995
595
0.030
Why?
Diffusion of Innovation
1
1994
71
0.030
Why?
Receptors, Estrogen
1
1995
385
0.030
Why?
Genetic Diseases, Inborn
1
1994
101
0.030
Why?
Health Care Costs
1
1995
232
0.030
Why?
Patient-Centered Care
1
1995
203
0.030
Why?
Forecasting
1
1994
303
0.030
Why?
Imaging, Three-Dimensional
1
2016
586
0.030
Why?
Molecular Targeted Therapy
1
2014
278
0.030
Why?
Adenoviridae
2
2004
347
0.030
Why?
Social Change
1
1991
7
0.020
Why?
England
1
1991
41
0.020
Why?
Acquired Immunodeficiency Syndrome
1
1991
80
0.020
Why?
Maximum Tolerated Dose
1
2011
271
0.020
Why?
Cluster Analysis
1
2011
369
0.020
Why?
Costs and Cost Analysis
1
1991
154
0.020
Why?
Databases, Genetic
1
2011
263
0.020
Why?
Promoter Regions, Genetic
2
2004
951
0.020
Why?
Precision Medicine
1
2014
406
0.020
Why?
Carcinoma, Squamous Cell
1
1996
1087
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
20
0.020
Why?
Etanercept
1
2008
33
0.020
Why?
Esophageal Neoplasms
2
2002
326
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
43
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2008
90
0.020
Why?
Health Knowledge, Attitudes, Practice
1
1993
514
0.020
Why?
Double-Blind Method
1
1991
1706
0.020
Why?
Rats
2
2004
4012
0.020
Why?
Immunoglobulin G
1
2008
462
0.020
Why?
Delivery of Health Care
1
1991
426
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2011
1232
0.020
Why?
Retrospective Studies
1
2000
8701
0.020
Why?
Necrosis
2
1996
205
0.020
Why?
Endothelial Cells
1
2008
448
0.020
Why?
Reproducibility of Results
1
2011
2733
0.020
Why?
Pleural Effusion
1
2004
47
0.020
Why?
Organoplatinum Compounds
1
2004
95
0.020
Why?
Acetylcysteine
1
2004
69
0.010
Why?
Recombinant Fusion Proteins
2
1996
562
0.010
Why?
Biopsy, Needle
1
2004
234
0.010
Why?
Immunosuppressive Agents
1
2008
984
0.010
Why?
Genes, erbB-2
1
2003
25
0.010
Why?
Probability
1
2004
356
0.010
Why?
Selective Estrogen Receptor Modulators
1
2003
34
0.010
Why?
Receptors, Steroid
1
2003
42
0.010
Why?
Paclitaxel
1
2004
461
0.010
Why?
Mice, Inbred C57BL
2
2000
3160
0.010
Why?
DNA, Complementary
1
2002
394
0.010
Why?
Phytotherapy
1
2003
133
0.010
Why?
Up-Regulation
1
2004
725
0.010
Why?
Isocoumarins
1
2000
7
0.010
Why?
Umbilical Veins
1
2000
46
0.010
Why?
Drug Resistance, Neoplasm
1
2004
608
0.010
Why?
Laminin
1
2000
88
0.010
Why?
Drug Combinations
1
2000
201
0.010
Why?
ROC Curve
1
2003
768
0.010
Why?
Proteoglycans
1
2000
123
0.010
Why?
Mass Screening
1
2004
624
0.010
Why?
Collagen
1
2000
276
0.010
Why?
Angiostatins
1
1998
15
0.010
Why?
Cytokines
1
2003
794
0.010
Why?
Endothelium, Vascular
1
2000
431
0.010
Why?
Colonic Neoplasms
1
2002
563
0.010
Why?
Cohort Studies
1
2004
2789
0.010
Why?
Cell Movement
1
2000
778
0.010
Why?
Biomarkers
1
2003
1731
0.010
Why?
Dose-Response Relationship, Drug
1
2000
1936
0.010
Why?
Mastadenovirus
1
1995
4
0.010
Why?
Liposomes
1
1995
92
0.010
Why?
Cells, Cultured
1
2000
2842
0.010
Why?
Neoplasms, Radiation-Induced
1
1995
109
0.010
Why?
Radiation Tolerance
1
1995
169
0.010
Why?
Transplantation, Heterologous
1
1995
370
0.010
Why?
Thrombosis
1
1996
301
0.010
Why?
Signal Transduction
1
2003
3327
0.010
Why?
Hellman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (303)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_